Development of hot-melt extrusion as a novel technique for the ...
Development of hot-melt extrusion as a novel technique for the ...
Development of hot-melt extrusion as a novel technique for the ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
medium pH w<strong>as</strong> maintained <strong>as</strong> 1.2 by using 750 ml <strong>of</strong> 0.1 M hydrochloric acid <strong>for</strong> 2 hr. After2 hr operation, 150 ml <strong>of</strong> 0.20 M solution <strong>of</strong> dehydrogenate sodium ortho phosphate w<strong>as</strong>added into <strong>the</strong> vessel to give <strong>the</strong> final pH <strong>of</strong> 6.8 and <strong>the</strong> temperature equilibrated to 37°C. Atpredetermined time intervals, samples were withdrawn <strong>for</strong> HPLC <strong>as</strong>say and replaced withfresh dissolution medium. All dissolution studies were per<strong>for</strong>med in triplicate.2.9 HPLC analysisThe rele<strong>as</strong>e <strong>of</strong> HCS from <strong>the</strong> prepared tablets w<strong>as</strong> determined by HPLC. An AgilentTechnologies system equipped with a HYCROME 4889, 5 m x 150 mm x 4 mm column at243 nm w<strong>as</strong> used <strong>for</strong> <strong>the</strong> HCS HPLC <strong>as</strong>say. The mobile ph<strong>as</strong>e consisted <strong>of</strong> methanol/water/acetic acid (54:45:1, v/v/v). The flow rate w<strong>as</strong> 1.5 ml/min and <strong>the</strong> retention time <strong>of</strong> HCS w<strong>as</strong>about 4 minutes. The HCS calibration curve (R 2 =0.999), at concentrations varying from 10µg/ml to 50 µg/ml, were used to evaluate all <strong>the</strong> samples with 20 µl injection volume.2.10 Analysis <strong>of</strong> drug rele<strong>as</strong>e mechanismZero order kinetics, first order kinetics, Hixson–Crowell, Higuchi and Korsmeyer–Pepp<strong>as</strong> models were used <strong>for</strong> <strong>the</strong> analysis <strong>of</strong> <strong>the</strong> dissolution mechanism taking <strong>the</strong> rateconstant obtained from <strong>the</strong>se models <strong>as</strong> an apparent rate constant. The drug rele<strong>as</strong>e patternsfrom both coated and uncoated tablets were analyzed by rele<strong>as</strong>e kinetics <strong>the</strong>ories [18-22] , <strong>as</strong>follows:Zero order kinetics: F K t (8.1)toWhere F t represents <strong>the</strong> fraction <strong>of</strong> drug rele<strong>as</strong>ed in time t and K 0 <strong>the</strong> apparent rele<strong>as</strong>e rateconstant or zero order rele<strong>as</strong>e constant.First order kinetics: ln( 1 F ) K (8.2)1 tWhere F represents <strong>the</strong> fraction <strong>of</strong> drug rele<strong>as</strong>ed in time t and K 1 is <strong>the</strong> first order rele<strong>as</strong>econstant.Higuchi model: F K t 1/ 22(8.3)Where F represents <strong>the</strong> fraction <strong>of</strong> drug rele<strong>as</strong>ed in time t and K 2 is <strong>the</strong> Higuchi dissolutionconstant.1/3 1/30 t stHixson–Crowell model: W W K (8.4)155 | P a g e